EIF2AK4 and pulmonary arterial hypertension: Current guidelines indicate that a diagnosis of heritable PVOD/PCH can be made by identifying pathogenic biallelic EIF2AK4 variants without necessitating lung biopsy [9, 18], which may pose a substantial risk for morbidity or mortality for a patient with severe pulmonary hypertension and/or right ventricular failure.